Analysen von Richard Vosser
| 19.07.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 19.07.24 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 18.07.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 17.07.24 | Bayer Neutral | JP Morgan Chase & Co. | |
| 17.07.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 16.07.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 11.07.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 11.07.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 10.07.24 | Bayer Neutral | JP Morgan Chase & Co. | |
| 05.07.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 04.07.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 03.07.24 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 03.07.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 02.07.24 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 27.06.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 25.06.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 24.06.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 24.06.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.06.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 11.06.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 04.06.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 03.06.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 03.06.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 03.06.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 24.05.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 22.05.24 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 20.05.24 | Bayer Neutral | JP Morgan Chase & Co. | |
| 16.05.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 14.05.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 14.05.24 | Bayer Neutral | JP Morgan Chase & Co. | |
| 10.05.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 07.05.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 03.05.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.05.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 02.05.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.04.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 25.04.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 24.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 23.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 22.04.24 | Bayer Neutral | JP Morgan Chase & Co. | |
| 22.04.24 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 18.04.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 18.04.24 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 15.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 15.04.24 | Bayer Neutral | JP Morgan Chase & Co. | |
| 12.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 05.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 03.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 02.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 28.03.24 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |